Annual report pursuant to Section 13 and 15(d)

Accrued Expenses and Other Current Liabilities

v3.3.1.900
Accrued Expenses and Other Current Liabilities
12 Months Ended
Dec. 31, 2015
Accrued Expenses and Other Current Liabilities  
Accrued Expenses and Other Current Liabilities

 

5. Accrued Expenses and Other Current Liabilities

        Accrued expenses and other current liabilities consisted of the following:

                                                                                                                                                                                    

 

 

December 31,

 

 

 

2015

 

2014

 

Compensation and benefits

 

$

2,599,565 

 

$

1,628,102 

 

Clinical trial expenses

 

 

401,029 

 

 

846,199 

 

Other research and development expenses

 

 

 

 

96,088 

 

Other accrued expenses and other current liabilities

 

 

29,188 

 

 

7,880 

 

​  

​  

​  

​  

Total accrued expenses and other current liabilities

 

$

3,029,782 

 

$

2,578,269 

 

​  

​  

​  

​  

​  

​  

​  

​